🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FISH testing is now available at our Naperville, USA laboratory! This means we provide FISH testing for global clinical trials across our US, EU, and China labs, with HER2 FISH being our first globally available assay. See ISH offerings: buff.ly/GPQtjld #FISHTesting

CellCarta's first Connect Challenge event in China is coming up! This invitation only event is an in-person interactive forum that highlights current drug development topics and needs in China. Want to attend? Register to receive an invitation: buff.ly/0ZaiBKn

Optimize target recognition, refine patient stratification, and assess on-target, off-tumor toxicities with our comprehensive testing services. See how we support your ADC program: buff.ly/f7MF4pY

Next week, our Associate Director of Digital Pathology Analysis & Development, Sofie Daelemans, will be sharing how CellCarta develops and validates image analysis algorithms. Join us at the in-person Visiopharm workshop in Paris to learn more! imageanalysis.visiopharm.com/registration-1…

Heading to the #ASCO25 Annual Meeting in Chicago, IL at the end of the month? Meet our team to find out why we’re the CRO partner of choice for: ⭐ Biomarker strategies ⭐ Scientific excellence ⭐ Trusted sample handling Book a meeting! 👇 buff.ly/PUoIuJ0

CellCarta Connect Challenge is an person invitation-only event bringing together top minds in science and medicine for a day of insights & valuable connections.  In Shanghai, or know a colleague interested in this event? Register to receive an invitation: buff.ly/tGA3N2c

We were thrilled to share how CellCarta develops and validates image analysis algorithms at the Visiopharm Paris User Group Meeting! Thanks to the Visiopharm team and Institute Pasteur for hosting- We had a great time connecting with other users. #ImageAnalysis #Biomarkers

Unsure how to transition your clinical trial assay to companion diagnostic (CDx)? Our experts can help. Learn more here 👉 buff.ly/inKzOAf #ClinicalTrials #PrecisionMedicine #CDx

We're excited to attend #CYTO2025 in Denver! Join us for this event on the cutting edge of flow cytometry research. Don't miss poster P336 on how we efficiently track electronic noise across our cytometers to ensure high-quality, high-consistency data. buff.ly/hbKzfZp

Will you be at #CYTO2025? Visit Dominic Gagnon's poster on electronic noise tracking! Poster: P336 Presenter: Dominic Gagnon Date: June 3, 5:00 PM - 6:30 PM Book a meeting with our experts: buff.ly/TPVmwWf

Will you be at #ASCO25? CellCarta is proud to have contributed to abstract #4509. Our spatial, data science & digital pathology specialists were key in generating immune cell infiltration data, predictive of no reoccurrence following checkpoint inhibition combined with axitinib.

Optimize target recognition, refine patient stratification, and assess on-target, off-tumor toxicities with our comprehensive testing services. See how CellCarta supports your ADC program: buff.ly/mHgfCXW

Milan is calling our names! Will you be at #EHA2025? Book a meeting with our team and learn how our comprehensive services can support your hematology and immuno-oncology projects. Book a meeting today: buff.ly/Ri19x8w

May is National Cancer Research Month, a time to highlight the efforts of our scientists and breakthroughs in cancer research. We're committed to helping scientists advance their cancer research and develop more effective diagnostics and treatments for patients.

ASCO is in full swing, and the CellCarta team is thrilled to be here! It's already been a busy weekend, and we're looking forward to three more days of scientific insights and connections! Schedule a meeting with someone from our team attending ASCO: buff.ly/Ri19x8w

Our team is having a great time in Denver, keeping up to date with the latest in the field of cytometry! Interested in learning more about our flow cytometry and data analysis offerings? Our team excited to learn about your projects. #CYTO2025 #FlowCytometry

T cell engagers (TCEs) are typically bispecific antibodies that bind a disease-associated antigen and a T cell, activating cytotoxic responses to eliminate pathogenic cells. See how you can get the data needed to advance TCE development in our new post: buff.ly/rIOhrPA

Measuring cytokines? The right platform is key. Our experts guide you through Olink, MSD, and ELLA options for precise and reliable analysis: buff.ly/FW6veu4 #PrecisionMedicine #CytokineMeasurement #Immunoassay

CellCarta is proud to be the first and only CRO to utilise the VENTANA TROP2 (EPR20043) RxDx Device for patient selection in clinical trials.   Interested in applying a digital pathology approach to your patient selection in clinical trials? Reach out: buff.ly/pjhRCyS

T cell engagers are taking off, with eight approvals in the past three years. We're excited to be attending this years T Cell Engager Summit - book a meeting to see how CellCarta can accelerate your clinical success with comprehensive TCE support! buff.ly/MW1ZBKO